RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
cIMPACT-NOW Update 7: Advancing the Molecular Classification of Ependymal Tumors https://t.co/x0DHP4FHMK #pathologist #NeuroPath #MolDx #Molpath https://t.co/0FbRgMD1bA
Myxopapillary EPN cases are getting bumped to G2 and the MYCN variant of spinal EPN is recognized as a distinct entity... cIMPACT-NOW Update 7: advancing the molecular classification of ependymal tumors. https://t.co/AnFgEV21LA
RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
Pubmed: cIMPACT-NOW Update 7: advancing the molecular classification of ependymal tumors. https://t.co/8gEmKR3m3x
RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
Hot off the press! cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors https://t.co/as5FjqgRig
RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
RT @NeuropathClinic: cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
cIMPACT‐NOW Update 7: advancing the molecular classification of ependymal tumors. #neuropath https://t.co/xHhTqmXHNp
New in Pubmed: "cIMPACT-NOW Update 7: advancing the molecular classification of ependymal tumors." https://t.co/Y2JZRI6p3x